Tim Illidge - Dissemin

Papers authored by Tim Illidge

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2015 Owen A. O'Connor, Barbara Pro, Tim Illidge

, Lorenz H. Trumper, Emily K. Larsen, Dana A. Kennedy, Thomas John Manley

Phase III trial of brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients (pts) with CD30+mature T-cell lymphomas (MTCL).

Upload

John Radford, Tim Illidge

, Sally Barrington

PET- Directed Therapy for Hodgkin's Lymphoma REPLY

Upload

This paper is available in a repository.

Tim Illidge

, John A. Radford, Nicholas Counsell, Barry Hancock, Ruth Pettengell, Peter Johnson, Jennie Wimperis, Dominic Culligan, Bilyana Popova, Paul Smith, Andrew McMillan, Alison Brownell, Anton Kruger, Andrew Lister, Peter Hoskin and 2 other authors

Results of a trial of PET-directed therapy for early stage Hodgkin's lymphoma

Download from kclpure.kcl.ac.uk

This paper is made freely available by the publisher.

2014 Richard Hoppe, Tim Illidge

, Lena Specht, Ivan Vogelius, Joachim Yahalom

Comment on: “Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)”

Download from theoncologist.alphamedpress.org

Tim Illidge

, Cheadle Ej, Claire Donaghy, J. Honeychurch, Cheadle EJ Donaghy C Honeychurch J. . Illidge T.

Update on obinutuzumab in the treatment of B-cell maligancies

Upload

Michelle A. Fanale, Horwitz Sm, Fanale Ma, M. A. Fanale, Steven M. Horwitz, Andres Forero-Torres, Bartlett Nl, Nancy L. Bartlett

, Advani Rh, Ranjana H. Advani, Barbara Pro, Horwitz SM Forero-Torres A. Bartlett NL Advani RH Pro B. Chen RW Davies A. Illidge T. Huebner D. Kennedy DA Shustov Ar Fanale, Robert W. Chen, Chen Rw, Andrew Davies and 6 other authors

Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study

Download from doi.org

Simon J. Dovedi, Graznya Lipowska-Bhalla, Eleanor Cheadle, Edmund Poon, Michelle Morrow, Ross Stewart, Robert W. Wilkinson, Jamie Honeychurch, Timothy Illidge

Abstract 5034: The antitumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Download from www.researchgate.net

Simon J. Dovedi, Amy L. Adlard, Grazyna Lipowska-Bhalla, Conor McKenna, Sherrie Jones, Amy L. Adlard Grazyna Lipowska-Bhalla Conor McKenna Sherrie Jones Eleanor J. Cheadle Ian J. Stratford Edmund Poon Michelle Morrow Ross Stewart Hazel Jones Robert W. Wilkinson Jamie Honeychurch and Tim M. Illidge Simon J. Dovedi, Eleanor J. Cheadle, Ian J. Stratford, Edmund Poon, Michelle Morrow, Ross Stewart, Hazel Jones, Robert W. Wilkinson

, Jamie Honeychurch, Amy L. Adlard Grazyna Lipowska-Bhalla Conor McKenna Sherrie Jones Eleanor J. Cheadle Ian J. Stratford Edmund Poon Michelle Morrow Ross Stewart Hazel Jones Robert W. Wilkinson Jamie Honeychurch and Tim Illidge Simon J. Dovedi and 2 other authors

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

Download from aacrjournals.org

Oliver Kepp, Laura Senovilla, Ilio Vitale

, Erika Vacchelli, Sandy Adjemian, Patrizia Agostinis, Lionel Apetoh

, Fernando Aranda, Vincenzo Barnaba, Norma Bloy, Laura Bracci, Karine Breckpot

, David Brough, Aitziber Buqué, Maria G. Castro and 71 other authors

Consensus guidelines for the detection of immunogenic cell death

Download from lirias.kuleuven.be

Christian Gisselbrecht, Peter Borchmann, Francesco Annibale D'Amore, Timothy M. Illidge

, Pier Luigi Zinzani, Borchmann P D'Amore F Illidge TM Zinzani Pl Gisselbrecht C.

Challenging CD30-positive lymphomas - Current challenges, new insights and future directions: Joining a conversation on CD30+ lymphomas

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

T. Illidge

, G. Lipowska-Bhalla, E. Cheadle, J. Honeychurch, E. Poon, M. Morrow, R. Stewart, R. Wilkinson, S. Dovedi

Radiation Therapy Induces an Adaptive Upregulation of PD-L1 on Tumor Cells Which May Limit the Efficacy of the Anti-Tumor Immune Response But Can Be Circumvented by Anti-PD-L1

Upload

M. V. Maraldo, B. Dabaja, J. Garcia, J. Hadley, T. Illidge

, P. M. Petersen, D. A. Schut, R. Tsang, L. Specht

Radiation Therapy Planning for Early Stage Hodgkin Lymphoma: Experiences of the International Lymphoma Radiation Oncology Group

Upload

Tim Illidge

, Reda Bouabdallah, Robert Chen, Ajay K. Gopal

, Craig H. Moskowitz, Radhakrishnan Ramchandren, Andrei R. Shustov, Herve Tilly, Tanya M. Trippett, Adam Gibb, Laurie E. Grove, Ranjana Advani, Bouabdallah R Chen R Gopal AK Moskowitz CH Ramchandren R Shustov AR Tilly H Trippett TM Gibb A Grove LE Advani R. Illidge T.

Allogeneic Transplant Following Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma

Upload

Tim Illidge

, Lena Specht, Joachim Yahalom, Berthe Aleman, Anne Kiil Berthelsen, Louis Constine, Specht L. Yahalom J. Aleman B. Berthelsen AK Constine L. Dabaja B. Dharmarajan K. Ng A. Ricardi U. Wirth A; International Lymphoma Radiation Oncology Group Illidge T., Bouthaina Dabaja, Kavita Dharmarajan, Andrea Ng, Umberto Ricardi, Andrew Wirth, International Lymphoma Radiation Oncology Group

Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group

Download from iris.unito.it

Peter J. Hoskin, Amy A. Kirkwood, Bilyana Popova, Paul Smith, Martin Robinson, Eve Gallop-Evans, Stewart Coltart, Timothy M. Illidge

, Krishnaswamy Madhavan, Caroline Brammer, Patricia Diez, Andrew Jack, Isabel Syndikus, Kirkwood AA Popova B Smith P Robinson M Gallop-Evans E Coltart S Illidge T Madhavan K Brammer C Diez P Jack A Syndikus I. Hoskin Pj

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial

Upload

Tim Illidge

, Eleanor Cheadle Claire Donaghy Jamie Honeychurch Tim Illidge, Eleanor J. Cheadle, Claire Donaghy, Jamie Honeychurch

Update on obinutuzumab in the treatment of B-cell malignancies

Upload

Simon Dovedi, Amy Adlard, Grazyna Lipowska-Bhalla, Conor McKenna, Sherrie Jones, Eleanor Cheadle, Ian Stratford, Edmund Poon, Michelle Morrow, Ross Stewart, Hazel Jones, Robert W. Wilkinson, Jamie Honeychurch, Tim Illidge

The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade

Download from dx.doi.org

C. Pollard, A. Adlard, J. Honeychurch, T. Illidge

, S. Dovedi

Characterising changes in the immune cell population of the tumour microenvironment following treatment with external beam ionising radiation and a TLR7 agonist

Upload

Owen A. O'Connor, Barbara Pro, Tim Illidge

, Lorenz H. Trumper, Emily K. Larsen, Dana A. Kennedy

Phase 3 trial of brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients (pts) with CD30+mature T-cell lymphomas (MTCL)

Upload

Gp P. Collins, British Society of Blood and Marrow Transplantation, An N. Parker, Christopher Pocock, Irfan Kayani, Anna Sureda, Tim Illidge

, Kirit Ardeshna, Dc C. Linch, Ks S. Peggs, British Committee for Standards in Haematology

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma.

Download from onlinelibrary.wiley.com

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

Papers authored by Tim Illidge